SpringWorks Therapeutics

Director, Value, Access & Pricing- US Rare Tumors (TGCT)

SpringWorks Therapeutics$167K — $230K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree in business or related field
  • MBA or other advanced degree preferred
  • 9+ years in pharmaceutical and/or biotech (rare disease or oncology)
  • 5+ years in internal market access role
  • Experience with rare disease/oncology launch
  • Value/payer marketing expertise
  • Collaborative experience in a dynamic environment

Responsibilities

  • Act as market access expert and primary contact for access-related topics
  • Lead development of Market Access strategies and payor value propositions
  • Develop resources for field teams including Strategic Enterprise Account Directors and Field Access Managers
  • Shape pricing and contracting strategies for market competitiveness
  • Manage Pricing and Government Pricing lifecycle compliance
  • Evaluate market dynamics to inform access strategies
  • Manage key strategic partner relationships to execute tactical goals

Benefits

  • Best-in-class benefits package
  • Discretionary annual bonus based on performance
  • Generous PTO and flexible work policies
  • Opportunities for professional development and growth
  • Supportive work environment focused on patient advocacy
Full Job Description
Your Role:

The Director, Value, Access & Pricing (VAP) is a critical leadership role within the U.S. Market Access team, responsible for shaping the strategic direction and leading the development and execution of market access and pricing strategies to support the commercial success of pimicotinib for TGCT.

This individual will lead the development of access strategies and tactics that communicate the differentiated value of pimicotinib to key external stakeholders-including payers, C-suite executives, provider networks, GPOs, pharmacists, and population-based decision-makers in community oncology. The Director will be accountable for delivering a suite of payer and provider-facing tools, field team resources, and non-personal engagement tactics to ensure optimal access and uptake.

The Director will work in close partnership with the broader U.S. Market Access and collaborate closely with cross-functional partners including brand marketing, sales, HEOR, medical affairs, patient services, and operations to ensure strategic alignment and execution excellence

Location Classification - Hybrid:

This role will be required to work onsite 3 days a week or more as business needs require #LI-Hybrid

Essential Duties and Responsibilities:
  • Act as the product-specific market access expert and central hub for all access-related topics, serving as the primary point of contact for cross-functional teams and informing the broader U.S. Market Access organization on product-specific developments, strategies, and insights
  • Leads the development of Market Access strategies and evidence-based payor value proposition; manages the execution of brand aligned Market Access tactical plans that influence coverage decisions and remove patient access hurdles
  • Leads strategic and tactical development and pull through of various field-based resources to support field facing teams including Strategic Enterprise Account Directors (SEADs), Field Access Managers (FAMs), and Sales teams
  • Shapes the development of pricing and contracting strategies, ensuring market competitiveness, payor acceptance and coverage policies that enable patient access
  • Manage Pricing and Government Pricing annual lifecycle, including both strategic and operational activities to maintain compliance with regulations
  • Continuously evaluates changing market and competitive dynamics to inform short and long-term strategies including but not limited to formulary positioning, contracting, pricing, real-world evidence generation and public policy
  • Leads the management of key strategic partner relationships to ensure execution of the strategic vision and tactical goals as well as the timely completion of projects within budget
  • Monitor evolving reimbursement and policy landscape and integrate insights into access strategy
  • Measure and report impact of targeted launch / access tactical plan investments

Role Requirements:

Education:
  • Bachelor's degree (business or related disciplines)
  • MBA or other advanced degree preferred

Skills/Experience:
  • 9+ years of pharmaceutical and/or biotech experience required in rare disease or Oncology
  • 5+ years in internal Market access role
  • Internal rare disease/oncology launch experience required (strategic, operational and tactical)
  • Inline rare disease/oncology product market access and cross-functional brand team experience required
  • Value/payer marketing and customer insights generation experience required
  • Field and/or field payer experience preferred
  • New Product Pricing experience preferred
  • Understanding of Oncology value frameworks, HeOR, pricing, policy and patient advocacy preferred
  • Experience in patient administered products (Part D, oral)
  • Experience working a collaborative, dynamic, accountable environment

Technical:
  • Expert in US market access environment with knowledge of recent policy changes, external product launches and current dynamics in Rare & Oncology

Other:
  • Collaborative and curious, with innovative drive and continuous improvement mindset
  • Ability to travel to market access internal and external customer-facing meetings 30-40%

Leadership:
  • Inclusive, humble, people-first leader with demonstrated examples of successful collaboration and engagement in a fast-moving environment

Communication:
  • Strong communication both written and verbal
  • Ability to influence up and across to achieve strategic objectives, gain alignment and secure resources

Compensation and Benefits:The expected salary range for this position is $167,000 - $230,000. Actual pay will be determined based on experience, qualifications, location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance.

We offer best-in-class benefits for our team of SpringWorkers who work with urgency on behalf of patients suffering from devastating diseases. Interested in learning more, review additional information here Benefits.

About SpringWorks Therapeutics

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for rare diseases and cancer. The company was founded in 2017 and is headquartered in Stamford, Connecticut. SpringWorks Therapeutics focuses on developing targeted therapies that address the underlying biology of diseases. The company's lead product candidate, nirogacestat, is being developed for the treatment of desmoid tumors, a rare and debilitating disease. SpringWorks Therapeutics has partnerships with several academic institutions and pharmaceutical companies, including Pfizer and BeiGene.
Learn more about SpringWorks Therapeutics
Size
190 employees
Market Cap
$1.4 billion
Industry
Net Income
-$45.5 million
Founded
2017
Revenue
$35 million
NASDAQ

Similar Jobs

More Jobs at SpringWorks Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Director, Value, Access & Pricing- US Rare Tumors (TGCT) jobs: